v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   30,974,559    
Beginning balance at Dec. 31, 2024 $ 68,151,724 $ 30,975 $ 199,070,421 $ (130,949,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 2,201,909   2,201,909  
Net Loss (11,103,319)     (11,103,319)
Ending balance (in shares) at Mar. 31, 2025   30,974,559    
Ending balance at Mar. 31, 2025 59,250,314 $ 30,975 201,272,330 (142,052,991)
Beginning balance (in shares) at Dec. 31, 2024   30,974,559    
Beginning balance at Dec. 31, 2024 68,151,724 $ 30,975 199,070,421 (130,949,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net Loss (28,728,191)      
Ending balance (in shares) at Jun. 30, 2025   30,988,108    
Ending balance at Jun. 30, 2025 43,676,709 $ 30,988 203,323,584 (159,677,863)
Beginning balance (in shares) at Mar. 31, 2025   30,974,559    
Beginning balance at Mar. 31, 2025 59,250,314 $ 30,975 201,272,330 (142,052,991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense (in shares)   3,750    
Stock-based compensation expense 2,033,109 $ 4 2,033,105  
Purchases under employee stock purchase plan (in shares)   9,799    
Purchases under employee stock purchase plan 18,158 $ 9 18,149  
Net Loss (17,624,872)     (17,624,872)
Ending balance (in shares) at Jun. 30, 2025   30,988,108    
Ending balance at Jun. 30, 2025 43,676,709 $ 30,988 203,323,584 (159,677,863)
Beginning balance (in shares) at Dec. 31, 2025   33,378,139    
Beginning balance at Dec. 31, 2025 20,024,175 $ 33,379 206,865,282 (186,874,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense (in shares)   937    
Stock-based compensation expense 1,496,990 $ 1 1,496,989  
Exercise of pre-funded warrants   $ 1,748 (1,748)  
Exercise of pre-funded warrants (in shares)   1,747,808    
Net Loss (12,509,361)     (12,509,361)
Ending balance (in shares) at Mar. 31, 2026   35,126,884    
Ending balance at Mar. 31, 2026 9,011,804 $ 35,128 208,360,523 (199,383,847)
Beginning balance (in shares) at Dec. 31, 2025   33,378,139    
Beginning balance at Dec. 31, 2025 $ 20,024,175 $ 33,379 206,865,282 (186,874,486)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Purchases under employee stock purchase plan (in shares) 8,400      
Net Loss $ (23,295,955)      
Ending balance (in shares) at Jun. 30, 2026   35,143,722    
Ending balance at Jun. 30, 2026 (497,307) $ 35,144 209,637,990 (210,170,441)
Beginning balance (in shares) at Mar. 31, 2026   35,126,884    
Beginning balance at Mar. 31, 2026 9,011,804 $ 35,128 208,360,523 (199,383,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense (in shares)   8,438    
Stock-based compensation expense 1,271,209 $ 8 1,271,201  
Purchases under employee stock purchase plan (in shares)   8,400    
Purchases under employee stock purchase plan 6,274 $ 8 6,266  
Net Loss (10,786,594)     (10,786,594)
Ending balance (in shares) at Jun. 30, 2026   35,143,722    
Ending balance at Jun. 30, 2026 $ (497,307) $ 35,144 $ 209,637,990 $ (210,170,441)